Measles Vaccine Potency and Sero-Conversion Rates among Infants Receiving Measles Immunization in Ilorin, Kwara State, Nigeria

REFERENCES

• Akande, T.M. A Review of Measles Vaccine Failure in Developing Countries. Nig. Med. Pract. 2007, 52(5–6), 112–116.
   Google Scholar
• Adu, F.D.; Adeniji, J.A. (1995): Measles Antibodies in the Breast Milk of Nursing Mothers. Afr. J. Med. Med. Sci. 1995, 24, 385–388.
   PubMedGoogle Scholar
• Odoemele, C.F.; Ukwandu, N.C.D.; Adu, F.D.; Nmorsi, O.P.G.; Omotade, O.O. Effect of Measles Virus Antibodies from Breast Milk of Nursing Mothers on Seroconversion of Children After Measles Vaccination. Shiraz E-Med. J. 2006, 7(2).
   Google Scholar
• Maldonado, Y. Measles. In Nelson Textbooks of Paediatrics, 17th ed.; Berhaman, R.E., Kleigman, R.M., Jensen, H.B. Saunders Publishers: Philadelphia, 2004; pp 1026–1031.
   Google Scholar
• Commey, J.O.; Dekyem P. Measles in Southern Ghana; 1985–1993, W. Afr J. Med. 1994, 13, 223–226.
   Google Scholar
• MMWR Update: Global measles control and mortality reduction worldwide, 1991-2001. Morbidity, Mortality, Weekly Rep. 2003; 52: 471–475.
   PubMedGoogle Scholar
• Centers for Disease Control and Prevention. Measles Eradication: Recommendations from a Meeting Cosponsored by the World Health Organization and CDC. MMWR. 1997, 46(RP–11), 1–20.
   PubMedGoogle Scholar
• Wondigatir, N.; Nokes, D.J.; Cohen, B.J.; Brown, D.W.G.; Vyse, A.J. Pre-and Post-vaccine Measles Antibody Status using Serum and Oral Fluid Testing: An Evaluation of Routine Immunization in Addis Ababa, Ethiopia. Ethiop J. Health Dev. 2003, 17(3), 149–155.
   Google Scholar
• Okonko, I.O.; Nkang, A.O.; Udeze, A.O.; Adedeji, A.O; Ejembi, J.; Onoja, B.A.; Ogun, A.A.; Garba, K.N. Global Eradication of Measles: A Highly Contagious and Vaccine Preventable Disease- What Went Wrong in Africa? J. Cell. Animal Biol. 2009, 3(8), 119–140.
   Google Scholar
• Okonko, I.O.; Onoja, B.A.; Adedeji, A.O.; Ogun, A.A.; Udeze, A.O.; Ejembi, J.; Garba, K.N.; Egun, O.C.; Fowotade, A. The Role of Vaccine in Elimination and Global Eradication of Measles—A Review Of Literature. Afr. J Pharm. 2009, 3(9), 413–425.
   Web of Science ®Google Scholar
• World Health Organization. Expanded Programme on Immunization. On Immunization Accelerated Measures Strategies. Wkly. Epidemiol. Rec. 1994, 23, 185–193.
   Google Scholar
• Oyefolu, A.O.; Omilabu, S.A. Measles HI Antibody Levels in Lagos Children, Nigeria: A Follow-Up Study to Resurgence of Measles in Lagos Metropolis. W. Afr. J. Med. 2001, 20(3), 238–242.
   PubMedGoogle Scholar
• Oyedele, O.O.; Odemuyiwa, S.O.; Ammerlaan, W.; Muller, C.P.; Adu, F.D. Passive Immunity to Measles in the Breast Milk and Cord Blood of Some Nigerian Subjects. J. Trop Paediatr. 2005, 51, 45–48.
   PubMed Web of Science ®Google Scholar
• Onoja, A.L.; Adu, F.D.; Tomori, O. Evaluattion of Measles Vaccination Programme Conducted in Two Separate Health Centres. Vaccine 1992, 10, 49–52.
   PubMed Web of Science ®Google Scholar
• Odoemele, C.F.; Ukwandu, N.C.; Adu, F.D.; Nmorsi, O.P.; Anyanwu, L.C.; Oduke, M.A.; Omotade, O.O. Seroconversion of Children Following Natural Measles Infection and Vaccination. J. Pak. Med. 2008, 58(9), 501–505.
   PubMedGoogle Scholar
• Baba, M.M.; Omede, S.C.; Omotade, B.A.; Ambe, J.P. Evaluation of Measles Vaccines in Northeastern Nigeria. Nat. Sci. 2007, 5(3), 49–53.
   Google Scholar
• Parent du Chatelet, D.; Floret, D.; Antonna, D.; Levy-Bunhl, D. Measles Resurgence in France in 2008, A Preliminary Report. Eurosurveillance 2009, 14(6), 1–3.
   Google Scholar
• Anne, S.Y.; Joseph, H.D.; Lawrence, A.R.; Biot, H. Measles Immunization, Success and Failures. JAMA 1977, 237, 347–351
   PubMed Web of Science ®Google Scholar
• Adu, F.D.; Akinwolere, O.A.O.; Tomori, O.; Uche, L.N. Low Seroconversion Rates to Measles Vaccine among Children in Nigeria. Bull. WHO 1992, 70(4), 457–460.
   PubMed Web of Science ®Google Scholar
• Wolfsu, C.J.; Srebet, P.M.; Gacie-Dobo, M.; Hoekstra, E.; Mcfarland, J.W.; Hersh, B.S. Has the 2005 Measles Mortality Reduction Goal Been Achieved? A National History Modeling Study. Lancet 2007, 369, 191–200.
   PubMed Web of Science ®Google Scholar
• Adetunji, O.; Olusola, E.; Ferdinad, F.; Olorunyomi, O.; Idowu, J.; Ademola, O. Measles among Hospitalized Children in Nigeria. Int. J. Paed. Nephrol. 2006, 7(1).
   Google Scholar
• Joshi, A.B.; Lumen, E.T.; Nandy, R.; Subedi, B.K.; Jayanta, B.L.; Wierzba, T.F. Measles Death in Nepal: Estimating The National Case Fatality Ratio. Bull WHO 2009, 87(6), 405–484.
   Google Scholar
• Centers for Disease Control and Prevention. Recommended Immunization Schedules for Persons aged 0 through 18 years. United States, 2009. CDC Recommend. Vaccine Sched. December 2008, 57(51,52)
   Google Scholar
• Araoye, M.O. Subjects Selection. In Research Methodology with Statistics for Health and Social Sciences. 1st ed.; Araoye, M.O., Ed.; Nathadex: Ilorin, 2003; pp 115–129.
   Google Scholar
• Nakano, J.H.; Miller, D.L.; Foster, S.O.; Brink, E.W. Micro-titer Determination of Measles Haemagglutination Inhibition with Filter Paper. J. Clin. Microbiol. 1983, 17(5), 860–863.
   PubMed Web of Science ®Google Scholar
• Reed, L.J.; Muench, H. End Point Titer Calculation. Amer. J. Hyg. 1938, 27, 493–497.
   Google Scholar
• World Health Organization. Manual of Laboratory Methods for Potency Testing of Vaccines Used in the World Health Organization Expanded Program on Immuunization, WHO/VSQ/97.04, 1997.
   Google Scholar
• Omilabu, S.A.; Oyefolu, O.A.; Ojo, O.O.; Audu, R.A. Potency Status and Efficacy of Measles Vaccine Administered in Nigeria. Afr. J. Med. Sci. 1999, 28, 209–212.
   Google Scholar
• World Health Organization. The Immunological Response: Measles, Immunological Basis for Immunization. Module 7, WHO/EPI/GEN/93, 17: P.1, 1993.
   Google Scholar
• Adu, F.D.; Odoemele, F.C.; Bamgboye, E. Effect of Measles Antibodies in the Breast Milk and Sera of Mother on Seroconversion to Measles Vaccine. Afr. J. Biomed. Res. 1999, 2(1),7–11.
   Google Scholar
• Aref E. Detection of the Presence of Measles Antibodies in Vaccinated Children. Alex J. Paed. 1989, 3, 165–169.
   Google Scholar
• Babaniyi, O.A.; Parakoyi, D.B.; Bello, M.A. Loss of Maternally Acquired Antibodies during Infancy in Ilorin, Nigeria. J. Trop. Paed. 1995, 41(2), 115–117.
   PubMed Web of Science ®Google Scholar
• Sadoh, A.E.; Eregie, C.O. Is Age at Commencement of Infant Immunization a Significant Determinant of Uptake in Nigeria? Nig. Hosp. Pract. 2009, 3(4), 34–37.
   Google Scholar
• Kimati, V.O.; Loretn, K.; Munub, G.M.R.; Kimboi, F. The Problem of Measles Virus, Response with Reference to Vaccine Stability, Age, Protein-Energy Malnutrition and Malaria in the Tropics. J. Trop. Paediatr. 1991, 27(4), 205–209.
   Google Scholar
• Abrecht, P.; Ennis, F.A.; Salzmann, E.J.; Krugman, S. Persistence of Maternal Antibody in Infants beyond 12 Months: Mechanism of Measles Vaccine Failure. J. Paediatr. 1977, 91, 915–918.
   Google Scholar
• Ogra, S.S.; Weintraub, D.; Ogra, P.L. Immunologic Aspects of Human Colostrum and Milk. J. Immunol. 1977, 119, 245–248.
   PubMed Web of Science ®Google Scholar
• Adu, F.D.; Adedeji, A.A.; Esan, J.S.; Odusanya, O.G. Live Viral Vaccine Potency: An Index for Assessing the Cold Chain System. Public Health 1996, 110, 325–330.
   PubMed Web of Science ®Google Scholar
• Adu, F.D.; Ikusika, A.; Omotade, O. Measles outbreak in Ibadan: Clinical, Serological and Virological Identification of Affected Children in Selected Hospitals in Ibadan. W. Afr. J. Med. 2000, 19(4), 1309–1311.
   Google Scholar
• Techthayat, S.; Varinsthan, P.; Rasdjarin, R.A.; Tharnapilornpilas, P. Exposure to Heat and Freezing in the Vaccine Cold Chain in Thailand. Immunization Programme, Bureau of General Communicable Diseases, Department of Disease Control. Ministry of Public Health Nonthabur. 11000, Thailand. 2007, 1328–1334.
   Google Scholar
• Saha, S.M.; Aggarai, R.; Swa, D.K.; Chakraborty, S.N. The Cold Chain in the Measles Immunization Programme in India. India J. Paed. 1998, 55(3), 356–358.
   Google Scholar
• Fransisco, A.; Hall, A.J.; Unicomb, L.; Chakaborty, Y.; Sack, R.B. Maternal Measles Antibody Decay in Rural Bangladesh Infants: Implication for Revaccination. Vaccine 1998, 16(6), 564–568.
   PubMed Web of Science ®Google Scholar